BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6208807)

  • 1. [Effect of hemodilution with plasma protein solution and hydroxyethyl starch on plasma fibronectin].
    Khosropour R; Graninger W; Lackner F
    Anasth Intensivther Notfallmed; 1984 Aug; 19(4):175-8. PubMed ID: 6208807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
    Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
    Penner M; Fingerhut D; Tacke A
    Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Volume substitution in acute normovolemic hemodilution. 5% human albumin vs. 6% hydroxyethyl starch].
    von Bormann B; Sticher J; Ratthey K; Idelberger R; Hempelmann G
    Infusionstherapie; 1990 Jun; 17(3):142-6. PubMed ID: 1697284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative autologous blood donation, effect of hydroxyethyl starch on the reticuloendothelial system and opsonins].
    Lackner FX; Graninger W; Ilias W; Panzer S; Schulz E
    Infusionstherapie; 1990 Oct; 17(5):276-9. PubMed ID: 1705248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
    Hausdörfer J; Hagemann H; Heine J
    Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
    Meyer P; Pernet P; Hejblum G; Baudel JL; Maury E; Offenstadt G; Guidet B
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):229-35. PubMed ID: 18034867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions].
    Vogt N; Bothner U; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 May; 29(3):150-6. PubMed ID: 7519062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of isovolaemic haemodilution on infection-related serum protein levels.
    Lackner FX; Graninger W; Khosropour R
    Eur J Anaesthesiol; 1985 Dec; 2(4):407-17. PubMed ID: 2417834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hydroxyethyl starch HES 450/0.7 and 5% human albumin on the colloid osmotic pressure and hemodynamic parameters in hypovolemic patients after major abdominal procedures].
    Gahr R; Bock PR
    Infusionsther Klin Ernahr; 1981 Jun; 8(3):147-52. PubMed ID: 6167516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
    Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of hydroxyethyl starch on postoperative alterations of blood coagulation (author's transl)].
    Vinazzer H; Bergmann H
    Anaesthesist; 1975 Dec; 24(12):517-20. PubMed ID: 56146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.